Year: 2025
Type: article
Study design: Clinical Trial
Abstract: COVID-19 is an infectious disease that is spreading both in Thailand and around the world. Affecting life, economy and society at the micro and macro levels. Therefore, it is important that effective treatment and management be in place. Molnupiravia treatment is one standard of treatment. But there are other alternatives in Thailand that have herbal medicines that have been used to treat diseases for thousands of years. Hence, Kerra herbs are used in the treatment of COVID-19. The researcher was therefore interested in comparing the efficacy and safety of herbal medicines Kerra and Molnupiravia on symptoms of early COVID-19 disease, a randomized controlled trial (RCT). The subjects were randomly assigned to the group by computer. data analysis Comparing the occurrence of COVID-19 patients between day one and days 3, 7, 10, 30 for each treatment regimen. Cochran's Q test comparing the occurrence of COVID-19 patients and ATK results between Kerra and The use of Molnupiravia on days 0, 3, 7, 10, 30 using Chi-square statistics showed that the incidence of COVID-19 patients between day one and days 3, 7, 10, 30 in each treatment regimen. The Cochran's Q test shows a trend in the number of asymptomatic cases of COVID-19. At the .001 level, the Kerra herb group and the Molnupiravia group were significantly different on day 7. The ATK test results were significantly different at the .05 level. 54.9% positive for ATK by drug treatment, while 69% by Kerra treatment. Checked on day 10 and up, no difference No severe symptoms were found and were referred to the sample. to receive further treatment at the hospital From the research, it will be seen that the herb Kerra will continue to be an alternative medicine for treating COVID-19.
Language: Thai
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7219232622